PubMed · 1979 · 10 citations · 0 references
Veterinary MedicineInfectious DiseasesVeterinary ParasitologyHelminthologyParasitologyVeterinary Parasitic DiseasesAnthelmintic PharmacologyHelminth InfectionsParasite ControlParasite PreventionParasitic Disease PreventionParasitic ZoonosesAlbendazole TherapyAnthelmintic AgentsAnthelmintic Drug TherapyAnthelmintic ProphylaxisAnthelmintic TreatmentAntihelminthic TherapyHelminth ChemotherapyVeterinary Anthelmintics
Anthelmintic trials were carried out to evaluate the efficacy of albendazole against helmi of 2,5 to 3,8 mg/kg administered orally, resulted in a 98,8 to 100% reduction of adult parasites of the genera Haemonchus, Ostertagia, Trichostrongylus, Nematodirus, Gaigeria, Oesophagostomum, Chabertia, Marshallagia and Cooperia. Against the immature stages of these genera, except for Marshallagia and Cooperia, which were not tested, a dose level of 2,5 to 3,8 mg/kg was 83,9-100% effective. Albendazole at 2,5 mg/kg was 99,0% effective against adult stages of Dictyocaulus; its activity at a dose of 3,8 mg/kg against the immature stages of D. filaria was 89,3%. In sheep naturally infested with Moniezia, 100% elimination was obtained at a dose level of 2,5 mg/kg. Dose levels of 3,8 mg/kg and higher were more than 76% effective against adult Fasciola hepatica, while a dose of 4,8 mg/kg was 63% effective against adult Fasciola gigantica.